Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Engerix-B Kinder Persistence and Challenge in Adolescents
NCT01847430Phase 4Completed
- Sponsor
- GSK
- Start
- Jul 2013
- Primary completion
- Feb 2014
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of hepatitis b vaccine recombinant in hepatitis B (HBV), sponsored by GSK. Started Jul 2013; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01847430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01847430.